Webinar: Ns Pharma Announcement Of Viltepso

Webinar: NS Pharma Announcement of VILTEPSO™ (August 2020)

Parent Project Muscular Dystrophy

[Webinar] NS Pharma Provides Viltolarsen Update - November 2019

Parent Project Muscular Dystrophy

Research Row Presentation: Viltepso (NS Pharma) - PPMD 2023 Annual Conference

Parent Project Muscular Dystrophy

CureDuchenne and NS Pharma - VILTEPSO

Webinar: Viltepso, An FDA-Approved Treatment for Patients Amenable to Exon 53 Skipping (March 2023)

Parent Project Muscular Dystrophy

Webinar: NS Pharma - Overview of New Exon Skipping Trials: Brogidirsen and NS-050/NCNP-03 (Mar 2024)

Parent Project Muscular Dystrophy

Webinar: Viltepso - A Treatment Option for Patients Amenable to Exon 53 Skipping (April 2021)

Parent Project Muscular Dystrophy

Community Webinar Series 2021: Exon Skipping and Introduction to NS Pharma

Jett Foundation

[Webinar] NS Pharma's Exon 53 Skipping Program: Trial Recruitment & Update - February 2017

Parent Project Muscular Dystrophy

[Webinar] NS Pharma's Exon 53 Skipping Program - November 2016

Parent Project Muscular Dystrophy

[Webinar] NS Pharma's Exon 53 Skipping Program Update - April 2018

Parent Project Muscular Dystrophy

In the Pipeline: Restoring Dystrophin - NS Pharma

Parent Project Muscular Dystrophy

VILTEPSO (viltolarsen)- Duchenne muscular dystrophy (DMD)

Pharmacy Talk USA

Community Webinar Series 2020: 1500 DMD Community Webinar on the FDA Approval VILTEPSO™ viltolarsen

Jett Foundation

Recently Reported Updates - NS Pharma (PPMD's 2021 Virtual Annual Conference)

Parent Project Muscular Dystrophy

The 1st RDODJ Ideological Collision Webinar——Duchenne Muscular Dystrophy

Trial Update: Exon 53 NS-065/NCNP-01 - NS Pharma [PPMD's 2017 Connect Conference]

Parent Project Muscular Dystrophy

Webinar: Santhera Pharmaceuticals Duchenne Drug Development Update (March 2021)

Parent Project Muscular Dystrophy

Webinar: Catabasis Phase 3 PolarisDMD Trial Results (October 2020)

Parent Project Muscular Dystrophy